Restricted accessResearch articleFirst published online 2024-7
Association of Higher Mediterranean Diet Adherence With Lower Prevalence of Disability and Symptom Severity,Depression,Anxiety,Stress,Sleep Quality,Cognitive Impairment,and Physical Inactivity in Older Adults With Multiple Sclerosis
A good nutritional status and healthy diets may decelerate disease disability and symptom severity and quality of life of peoples with multiple sclerosis (MS). Mediterranean diet (MD) can prevent several chronic diseases, including neurodegenerative disease. This is an observational, cross-sectional study on 279 older adults with MS, aiming to investigate the effects of MD against several aspects of mental health. Qualified questionnaires were used to assess disability and symptom severity, depression, anxiety, stress, sleep quality, cognitive status, physical activity, and MD adherence. Multivariate analysis showed that enhanced MD adherence was independently associated with lower prevalence of disability and symptom severity (P = .0019), depression (P = .0201), anxiety (P = .0287), perceived stress (P = .0021), inadequate sleep quality (P = .0033), cognitive impairment (P = .0018) and physical inactivity (P = .0028). Adopting MD may ameliorate mental health disturbances in older adults with MS. Future public health policies should inform older adults with MS for the favorable impacts of MD in improving the mental health MS comorbidities.
GhasemiNRazaviSNikzadE. Multiple sclerosis: Pathogenesis, symptoms, diagnoses and cell-based therapy. Cell J. 2017;19(1):1-10. doi:10.22074/cellj.2016.4867.
2.
KhanZGuptaGDMehanS. Cellular and molecular evidence of multiple sclerosis diagnosis and treatment challenges. J Clin Med. 2023;12(13):4274. doi:10.3390/jcm12134274.
3.
KlotzLAntelJKuhlmannT. Inflammation in multiple sclerosis: Consequences for remyelination and disease progression. Nat Rev Neurol. 2023;19(5):305-320. doi:10.1038/s41582-023-00801-6.
4.
GabyA. Multiple sclerosis. Glob Adv Health Med. 2013;2(1):50-56. doi:10.7453/gahmj.2013.2.1.009.
5.
VasileiouESFitzgeraldKC. Multiple sclerosis pathogenesis and updates in targeted therapeutic approaches. Curr Allergy Asthma Rep. 2023. online ahead of print. doi:10.1007/s11882-023-01102-0.
6.
PoppeAYWolfsonCZhuB. Prevalence of multiple sclerosis in Canada: A systematic review. Can J Neurol Sci. 2008;5(35):593-601. doi:10.1017/s0317167100009380.
7.
CapassoNVirgilioECovelliAet al.Aging in multiple sclerosis: from childhood to old age, etiopathogenesis, and unmet needs: A narrative review. Front Neurol. 2023;14:1207617. doi:10.3389/fneur.2023.1207617.
8.
WarrenSAJanzenWWarrenKGSvensonLWSchopflocherDP. Multiple sclerosis mortality rates in Canada, 1975-2009. Can J Neurol Sci. 2016;43(1):34-141. doi:10.1017/cjn.2015.236.
9.
BoikoAVorobeychikG. Paty D. Devonshire V, Sadovnick D. University of British Columbia MS Clinic Neurologists. Early onset multiple sclerosis: a longitudinal study. Neurology. 2022;59(7):1006-1010. 10.1212/wnl.59.7.1006.
10.
WallinMTCulpepperWJCampbellJDet al.US Multiple Sclerosis Prevalence Workgroup). The prevalence of MS in the United States: A population-based estimate using health claims data. Neurology. 2019;92:e1029-1040. doi:10.1212/WNL.0000000000007035.
11.
MacaronGLarochelleCArbourNet al.Impact of aging on treatment considerations for multiple sclerosis patients. Front Neurol. 2023;14:1197212. doi:10.3389/fneur.2023.1197212.
12.
MarrieRAFiskJDFitzgeraldKet al.Etiology, effects and management of comorbidities in multiple sclerosis: Recent advances. Front Immunol. 2023;14:1197195. doi:10.3389/fimmu.2023.1197195.
13.
JakimovskiDVaughnCBEckertSZivadinovRWeinstock-GuttmanB. Long-term drug treatment in multiple sclerosis: Safety success and concerns. Expert Opin Drug Saf. 2020;19(9):1121-1142. doi:10.1080/14740338.2020.1805430.
14.
JakimovskiDEckertSPZivadinovRWeinstock-GuttmanB (2021) Considering patient age when treating multiple sclerosis across the adult lifespan. Expert Rev Neurother.2021;21(3):353-364. doi: 10.1080/14737175.2021.1886082.
15.
OstolazaACorrozaJAyusoT. Multiple sclerosis and aging: Comorbidity and treatment challenges. Mult Scler Relat Disord. 2021;50:102815. doi:10.1016/j.msard.2021.102815.
16.
MoghadasiANMirmosayyebOBarzegarMSahraianMAGhajarzadehM. The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): A systematic review and meta-analysis. Neurol Sci. 2021;42(8):3093-3099. doi:10.1007/s10072-021-05373-1.
17.
De MoraisCOliveiraBAfonsoCLumbersMRaatsMde AlmeidaMDV (2013) Nutritional risk of European elderly. Eur J Clin Nutr.2013;67:1215-1219. doi:10.1038/ejcn.2013.175.
18.
KehoeLWaltonJFlynnA. Nutritional challenges for older adults in Europe: Current status and future directions. Proc Nutr Soc. 2019;78(2):221-233. doi:10.1017/S0029665118002744.
19.
RobinsonSM. Improving nutrition to support healthy ageing: What are the opportunities for intervention?Proc Nutr Soc. 2018;77:257-264. doi:10.1017/S0029665117004037.
20.
De Souza FernandesDPDuarteMSLPessoaMCFranceschiniSDCRibeiroAQ. Evaluation of diet quality of the elderly and associated factors. Arch Gerontol Geriatr. 2017;72:174-180. doi:10.1016/j.archger.2017.05.006.
21.
GiacomelloETonioloL. Nutrition, diet and healthy aging. Nutrients. 2021;14(1):190. doi:10.3390/nu14010190.
22.
PapadopoulouSKMantzorouMVoulgaridouGet al.Nutritional status is associated with health-related quality of life, physical activity, and sleep quality: a cross-sectional study in an elderly Greek population. Nutrients. 2023;15(2):443. doi:10.3390/nu15020443.
23.
MantzorouMVadikoliasKPavlidouEet al.Nutritional status is associated with the degree of cognitive impairment and depressive symptoms in a Greek elderly population. Nutr Neurosci. 2020;23(3):201-209. doi:10.1080/1028415X.2018.1486940.
24.
FeinsteinA. The neuropsychiatry of multiple sclerosis. Can J Psychiatry. 2004;49:157-163. doi:10.1177/070674370404900302.
25.
MargoniMPreziosaPRoccaMAFilippiM. Depressive symptoms, anxiety and cognitive impairment: emerging evidence in multiple sclerosis. Transl Psychiatry. 2023;13(1):264. 10.1038/s41398-023-02555-7.
26.
BinzerSMcKayKABrennerPHillertJManouchehriniaA. Disability worsening among persons with multiple sclerosis and depression: a Swedish cohort study. Neurology. 2019;93(24):e2216-e2223. doi:10.1212/WNL.0000000000008617.
27.
McKayKATremlettHFiskJDet al.Ruth ann marrie RA; CIHR team in the epidemiology and impact of comorbidity on multiple sclerosis. Psychiatric comorbidity is associated with disability progression in multiple sclerosis. Neurology. 2018;90:e1316–e1323. doi:10.1212/WNL.0000000000005302.
28.
MarrieRHorwitzRVollmerT. (2009). The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated. Mult Scler.2009;15(3):385-392. doi: 10.1177/1352458508099477.
29.
BrasanacJChienC. A review on multiple sclerosis prognostic findings from imaging, inflammation, and mental health studies. Front Hum Neurosci. 2023;17:1151531. doi:10.3389/fnhum.2023.1151531.
30.
MogaveroMPLanzaGBruniODelRossoLMFerriRFerini-StrambiL. Sleep counts! Role and impact of sleep in the multimodal management of multiple sclerosis. J Neurol. 2023;270(7):3377.
31.
EspositoSBonavitaSSparacoMGalloATedeschiG. The role of diet in multiple sclerosis: A.
32.
RiccioPRossanoR. Nutrition facts in multiple sclerosis. ASN Neuro. 2015;7(1):1759091414568185. doi:10.1177/1759091414568185.
33.
SamaraACantoniCPiccioLCrossAHChahinS. Obesity, gut microbiota, and multiple sclerosis: Unraveling the connection. Mult Scler Relat Disord. 2023;76:104768. doi:10.1016/j.msard.2023.104768.
34.
MangelsAR. CE malnutrition in older adults. Am J Nurs. 2018;118(3):34-41. doi:10.1097/01.NAJ.0000530915.26091.be.
35.
TsagaliotiETrifonosCMorariAVadikoliasKGiaginisC (2018) Clinical value of nutritional status in neurodegenerative diseases: What is its impact and how it affects disease progression and management?Nutr Neurosci.2018;21(3):162-175. doi:10.1080/1028415X.2016.1261529.
36.
SchwarzSLewelingH. Multiple sclerosis and nutrition. Mult Scler. 2005;11(1):24-32. doi:10.1191/1352458505ms1119oa.
37.
BäärnhielmMOlssonTAlfredssonL. (2014) Fatty fish intake is associated with decreased occurrence of multiple sclerosis. Mult Scler.2015;20(6):726-732. doi:10.1177/1352458513509508.
38.
WahlsTScottMOAlshareZet al.Dietary approaches to treat MS-related fatigue: comparing the modified Paleolithic (Wahls Elimination) and low saturated fat (Swank) diets on perceived fatigue in persons with relapsing-remitting multiple sclerosis: study protocol for a randomized controlled trial. Trials. 2018;19(1):309. doi:10.1186/s13063-018-2680-x.
39.
WahlsTL. Dietary approaches to treating multiple sclerosis-related symptoms. Phys Med Rehabil Clin N Am. 2022;33(3):605-620. doi:10.1016/j.pmr.2022.04.004.
40.
ItsiopoulosCMayrHLThomasCJ. The anti-inflammatory effects of a Mediterranean diet: A review. Curr Opin Clin Nutr Metab Care. 2022;25(6):415-422.
41.
FinicelliMDi SalleAGalderisiUPelusoG. The mediterranean diet: An update of the clinical trials. Nutrients. 2022;14(14):2956. doi:10.3390/nu14142956./MCO.0000000000000872.
42.
GantenbeinKVKanaka-GantenbeinC. Mediterranean diet as an antioxidant: The impact on metabolic health and overall wellbeing. Nutrients. 2021;13(6):1951. doi:10.3390/nu13061951.
43.
Katz SandIBennEKTFabianMet al.Randomized-controlled trial of a modified Mediterranean dietary program for multiple sclerosis: A pilot study. Mult Scler Relat Disord. 2019;36:101403. doi:10.1016/j.msard.2019.101403.
44.
Razeghi-JahromiSDoostiRGhorbaniZet al.A randomized controlled trial investigating the effects of a Mediterranean-like diet in patients with multiple sclerosis-associated cognitive impairments and fatigue. Curr J Neurol. 2020;19(3):112-121. doi:10.18502/cjn.v19i3.5424.
45.
SaresellaMMendozziLRossiVet al.Immunological and clinical effect of diet modulation of the gut microbiome in multiple sclerosis patients: A pilot study. Front Immunol. 2017;8:1391-1402. doi:10.3389/fimmu.2017.01391.
46.
Ertaş ÖztürkYHelvaciEMSökülmez KayaPTerziM. Is Mediterranean diet associated with multiple sclerosis related symptoms and fatigue severity?Nutr Neurosci. 2022:1-7. doi:10.1080/1028415X.2022.2034241.
47.
SedaghatFJessriMBehroozMMirghotbiMRashidkhaniB. Mediterranean diet adherence and risk of multiple sclerosis: A case-control study. Asia Pac J Clin Nutr. 2016;25(2):377-384. doi:10.6133/apjcn.2016.25.2.12.
48.
AlfredssonLOlssonTHedströmAK. Inverse association between Mediterranean diet and risk of multiple sclerosis. Mult Scler. 2023;29(9):1118-1125. doi:10.1177/13524585231181841.
49.
FarzinmehrSHosseiniSKamaliHMoghadasiANPoursadeghfardMSharifiMH. Association of self-reported adherence to the Mediterranean diet with anthropometric indices, comorbidities, and degree of disability in patients with multiple sclerosis. Mult Scler Relat Disord. 2022;66:104060. doi:10.1016/j.msard.2022.104060.
50.
WHO Expert Consultation. Appropriate body mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157-163. doi:10.1016/S0140-6736(03)15268-3.
51.
Kantz SandKI. Classification, diagnosis, and differential diagnosis of multiple sclerosis. Curr Opin Neurol. 2015;28(3):193-205. doi:10.1097/WCO.0000000000000206.
52.
Barreiro-GonzálezASanzMTCarratalà-BoscàSet al.Design and validation of an expanded disability status scale model in multiple sclerosis. Eur Neurol. 2022;85(2):112-121. doi:10.1159/000519772.
53.
KrishnamoorthyYRajaaSRehmanT. Diagnostic accuracy of various forms of geriatric depression scale for screening of depression among older adults: systematic review and meta-analysis. Arch Gerontol Geriatr. 2020;87:104002. doi:10.1016/j.archger.2019.104002.
54.
ChlanLSavikKWeinertC. Development of a shortened state anxiety scale from the Speilberger State-Trait Anxiety Inventory (STAI) for patients receiving mechanical ventilatory support. J Nurs Meas. 2003;11(3):283-293. doi:10.1891/jnum.11.3.283.61269.
55.
AndreouEAlexopoulosECLionisCet al.Perceived stress scale: Reliability and validity study in Greece. Int J Environ Res Public Health. 2011;8(8):3287-3298. doi:10.3390/ijerph8083287.
56.
SalahuddinMMaruTTKumaloAPandi-PerumalSRBahammamASManzarMD. Validation of the pittsburgh sleep quality index in community dwelling Ethiopian adults. Health Qual Life Outcomes. 2017;15(1):58. doi:10.1186/s12955-017-0637-5.
57.
CraigCLMarshallALSjostromMet al.International physical activity questionnaire: 12-country reliability and validity. Med Sci Sport Exerc. 2003;35(8):1381-1395. doi:10.1249/01.MSS.0000078924.61453.
58.
FountoulakisKNTsolakiMChantziHKazisA. Mini mental state examination (MMSE): A validation study in Greece. Am J Alzheimers Dis Other Demen. 2000;15(6):342-345. doi:10.1177/153331750001500604.
59.
PanagiotakosDBPitsavosCArvanitiFStefanadisC. Adherence to the Mediterranean food pattern predicts the prev-alence of hypertension, hypercholesterolemia, diabetes and obesity, among healthy adults; the accuracy of the MedDietScore. Prev Med. 2007;44(4):335-340. 10.1016/j.ypmed.2006.12.009.
IrishAKEricksonCMWahlsTLSnetselaarLGDarlingWG. Randomized control trial evaluation of a modified Paleolithic dietary intervention in the treatment of relapsing-remitting multiple sclerosis: A pilot study. Degener Neurol Neuromuscul Dis. 2017;7:1-18. doi:10.2147/DNND.S116949.
62.
LeeJEBishtBHallMJet al.A multimodal, nonpharmacologic intervention improves mood and cognitive function in people with multiple sclerosis. J Am Coll Nutr. 2017;36:150-168. doi:10.1080/07315724.2016.1255160.
63.
MaxwellKFWahlsTBrowneRWet al.Lipid profile is associated with decreased fatigue in individuals with progressive multiple sclerosis following a diet-based intervention: Results from a pilot study. PLoS One. 2019;14:e0218075. doi:10.1371/journal.pone.0218075.
64.
BrentonJNBanwellBBergqvistAGCet al.Pilot study of a ketogenic diet in relapsing-remitting MS. Neurol Neuroimmunol Neuroinflamm. 2019;6:e565. doi:10.1212/NXI.0000000000000565.
65.
BrentonJNLehner-GulottaDWoolbrightEet al.Phase II study of ketogenic diets in relapsing multiple sclerosis: Safety, tolerability and potential clinical benefits. J Neurol Neurosurg Psychiatry. 2022;93:637-644. doi:10.1136/jnnp-2022-329074.
66.
Armon-OmerAWaldmanCSimaanNNeumanHTamirSShahienR. New insights on the nutrition status and antioxidant capacity in multiple sclerosis patients. Nutrients. 2019;11:427. doi:10.3390/nu11020427.
67.
Mousavi-Shirazi-FardZMazloomZIzadiSFararoueiM. The effects of modified anti-inflammatory diet on fatigue, quality of life, and inflammatory biomarkers in relapsing-remitting multiple sclerosis patients: A randomized clinical trial. Int J Neurosci. 2021;31:657-665. doi:10.1080/00207454.2020.1750398.
68.
YadavVMarracciGKimEet al.Low-fat, plant-based diet in multiple sclerosis: a randomized controlled trial. Mult Scler Relat Disord. 2016;9:80-90. doi:10.1016/j.msard.2016.07.001.
69.
WahlsTLTitcombTJBishtBet al.Impact of the Swank and Wahls elimination dietary interventions on fatigue and quality of life in relapsing-remitting multiple sclerosis: The WAVES randomized parallel-arm clinical trial. Mult Scler J Exp Transl Clin. 2021;7(3):20552173211035399. doi:10.1177/20552173211035399.
70.
ChoiIYPiccioLChildressPet al.A diet mimicking fasting promotes regeneration and reduces autoimmunity and multiple sclerosis symptoms. Cell Rep. 2016;15(10):2136-2146. doi:10.1016/j.celrep.2016.05.009.
71.
SnetselaarLGCheekJJFoxSSet al.Efficacy of diet on fatigue and quality of life in multiple sclerosis: A systematic review and network meta-analysis of randomized trials. Neurology. 2023;100(4):e357-e366. doi:10.1212/WNL.0000000000201371.
72.
FerorelliPAntonelliFShevchenkoAet al.Reduction in fatigue symptoms following the administration of nutritional supplements in patients with multiple sclerosis. Med Sci. 2021;9(3):52. doi:10.3390/medsci9030052.
73.
TryfonosCMantzorouMFotiouDet al.Dietary supplements on controlling multiple sclerosis symptoms and relapses: Current clinical evidence and future perspectives. Medicines (Basel). 2019;6(3):95. 10.3390/medicines6030095.
